US Market Report for Dialysis Machines 2017 - MedCore is a new market research publication announced by Reportstack. General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
In-center hemodialysis accounted for the vast majority of the hemodialysis machine market, a trend that will continue over the forecast period. In-center treatment has been the standard for many years and has two major advantages over home-hemodialysis. The first advantage is that it is less costly as a result of not having to purchase the hemodialysis machine. The second advantage is that more of the care is taken out of the hands of the patient and placed with trained professionals that operate in-center. The sale of home hemodialysis machines will come primarily by new patients opting for the convenience of performing their dialysis treatments at home. Due to the small size of the home-hemodialysis market in comparison to the total dialysis market, there is a lot of room for growth. Increased penetration of the dialysis market will be vital to the growth of the home hemodialysis market. Similar to home hemodialysis, the peritoneal dialysis market is small with high growth potential. Despite the push from medical professionals, the transition of patients from in-center to home dialysis care is expected to have a slow uptake through to 2020. The safety advantages perceived at centers combined with limitations on the number of dialysis patients eligible for home treatments is projected to keep growth rates moderate.
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
In-center hemodialysis accounted for the vast majority of the hemodialysis machine market, a trend that will continue over the forecast period. In-center treatment has been the standard for many years and has two major advantages over home-hemodialysis. The first advantage is that it is less costly as a result of not having to purchase the hemodialysis machine. The second advantage is that more of the care is taken out of the hands of the patient and placed with trained professionals that operate in-center. The sale of home hemodialysis machines will come primarily by new patients opting for the convenience of performing their dialysis treatments at home. Due to the small size of the home-hemodialysis market in comparison to the total dialysis market, there is a lot of room for growth. Increased penetration of the dialysis market will be vital to the growth of the home hemodialysis market. Similar to home hemodialysis, the peritoneal dialysis market is small with high growth potential. Despite the push from medical professionals, the transition of patients from in-center to home dialysis care is expected to have a slow uptake through to 2020. The safety advantages perceived at centers combined with limitations on the number of dialysis patients eligible for home treatments is projected to keep growth rates moderate.
Complete report available @ US Market Report for Dialysis Machines 2017 - MedCore
The total dialysis patient population is expected to grow at a CAGR of 3.3% over the forecast period. The largest dialysis patient population, in-center hemodialysis, is expected to grow at a CAGR of 2.6%. The home hemodialysis patient population will grow at a CAGR of 7.4%, which will serve to drive growth of the overall dialysis market. ,A hemodialysis machine performs the critical tasks and drives hemodialysis treatments. A hemodialysis machine pumps blood from the body of the patient through a system of bloodlines and into the dialyzer. Dialysis fluids absorb toxins and excess water filtered out of the blood and then removes them from the body. The dialysis fluids are entered into the dialyzer through a separate cycle. Hemodialysis machines mix and monitor the dialysate used in each treatment. Dialysate is the dialysis fluid that serves to remove dangerous and unwanted waste products from the patient’s blood. A dialysis machine also adds an anti-coagulant drug into the blood.
Scope
2013-2023
2013-2023
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
No comments:
Post a Comment